SenesTech (NASDAQ:SNES) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a report issued on Monday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright increased their price target on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.

SenesTech Stock Performance

Shares of NASDAQ:SNES opened at $2.13 on Monday. The company has a current ratio of 6.32, a quick ratio of 4.92 and a debt-to-equity ratio of 0.05. SenesTech has a 1-year low of $1.90 and a 1-year high of $9.80. The stock has a market capitalization of $2.20 million, a P/E ratio of -0.21 and a beta of 0.09. The business has a 50-day moving average price of $2.95 and a two-hundred day moving average price of $2.82.

SenesTech (NASDAQ:SNES) last posted its quarterly earnings results on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The business had revenue of $0.50 million during the quarter, compared to the consensus estimate of $0.71 million. Equities analysts predict that SenesTech will post -10.22 earnings per share for the current year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.